En español
NIDA

Menu

Advancing Psychiatric Practice through the Science of Addiction

Special NIDA research track at the American Psychiatric Association's annual conference

May 07, 2013

The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, will present a special research track at the American Psychiatric Association’s (APA’s) 166th annual meeting in San Francisco from May 18 to 22. The NIDA sessions will highlight a wide range of topics to advance psychiatric practice through addiction science.

WHAT: Advancing Psychiatric Practice Through the Science of Addiction
NIDA special research track at the APA 166th annual meeting

WHEN: Saturday, May 18 – Wednesday, May 22, 2013

WHERE: Moscone Convention Center
www.moscone.com/pdf/MosconeParkingMap.pdf
San Francisco, Calif.

Media should register at www.xpressreg.net/register/apaa053/press/start.asp.

HIGHLIGHTS:

  • APA’s Opening Press Conference.
    During this opening press event and meeting overview, NIDA director Dr. Nora D. Volkow will provide a brief summary of the NIDA sessions.
    Saturday, May 18; 8:30 – 9:30 a.m.
    Yerba Buena Salon 1-3, Marriott Marquis Hotel, 55 Fourth Street
  • Addiction Performance Project. 
    Award-winning actress Mare Winningham leads an impressive cast in this innovative continuing medical education (CME) program, designed to help physicians incorporate screening, brief intervention, and referral to treatment. More information:www.drugabuse.gov/nidamed/about-addiction-performance-project/upcoming-performance-detailscme-ce-information/may-2013-san-francisco-ca.
    Sunday, May 19; 2 – 4 p.m.
    Room 130/131, Moscone Convention Center (North Building)
  • Frontiers of Science Lecture – Substance Use Disorders: New Scientific Findings and Therapeutic Opportunities.
    Dr. Volkow speaks on new findings and future directions for the treatment of substance use disorders.
    Monday, May 20; 11 a.m. – 12:30 p.m.
    Gateway Ballroom 102/103, Moscone Convention Center (South Building)
  • Evolutionary Explorations of the Human Genome.
    Special lecturer, Dr. Robert K. Moyzis from the University of California, Irvine, explores evolutionary implications of the human genome.
    Tuesday, May 21; 3:30 – 5 p.m.
    Gateway Ballroom 102/103, Moscone Convention Center (South Building)

OTHER NIDA SESSIONS:

  • Smoking Cessation in Patients with Severe Mental Illness: New Research Findings and Clinical Implications.
    Treating nicotine-dependent patients who have also been diagnosed with a substance use disorder or other mental disease.
  • Smoking and ADHD Comorbidity—Mechanisms and Clinical Implications.
    Nicotine use and cessation outcomes in smokers with ADHD.
  • Comorbid Psychiatric and Substance Use Disorders: Common and Specific Influences and Implications for Early Identification and Treatment.
    Common underlying mechanisms of and treatment for patients with co-occurring psychiatric and substance use disorders.
  • Advances in Pharmacotherapies for Substance Use Disorders.
    Current and future directions for medications to treat substance use disorders.
  • Cannabis Use and Youth: Updates on Risk, Assessment and Treatment.
    Effects of cannabis on the developing brain; screening and treatments for cannabis use disorders in youth.
  • Update on Prescription Opioid Abuse and Treatment Options for the Psychiatrist.
    Managing pain while limiting prescription opioid abuse in the psychiatric patient.

For more information on the APA annual meeting, visit http://annualmeeting.psychiatry.org/.


Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at www.drugabuse.gov. To order publications in English or Spanish, call NIDA's new DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or fax or email requests to 240-645-0227 or drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA's media guide can be found at www.drugabuse.gov/publications/media-guide, and its new easy-to-read website can be found at www.easyread.drugabuse.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

This page was last updated May 2013

News Releases

Jul 2014

Jun 2014

May 2014

Apr 2014

Mar 2014

Feb 2014

Jan 2014

Dec 2013

Nov 2013

Oct 2013

Sep 2013

Aug 2013

Jul 2013

Jun 2013

May 2013

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012

Jun 2012

May 2012

Apr 2012

Mar 2012

Feb 2012

Jan 2012

Dec 2011

Nov 2011

Oct 2011

Sep 2011

Aug 2011

Jul 2011

Jun 2011

May 2011

Apr 2011

Mar 2011

Jan 2011

Dec 2010

Nov 2010

Sep 2010

Aug 2010

Jul 2010

May 2010

Apr 2010

Mar 2010

Jan 2010